These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15196743)

  • 1. Is "no treatment" better than radiotherapy and chemotherapy?
    Debevec L
    Lung Cancer; 2004 Jul; 45(1):125; author reply 127. PubMed ID: 15196743
    [No Abstract]   [Full Text] [Related]  

  • 2. Do we need a size-based subclassification for lung cancers larger than 3 cm?
    Pramesh CS; Mistry RC; Agarwal J
    Lung Cancer; 2005 Jul; 49(1):133-4; author reply 135. PubMed ID: 15949601
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stage III NSCLC. The role of the chemotherapist].
    Westeel V
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S95-8. PubMed ID: 18971832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stage IIIB non-small cell lung cancer. Is there a recommended treatment? ].
    Fournel P
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S54-16S60. PubMed ID: 17268337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer].
    Fournel P
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S94-100. PubMed ID: 18235400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of locally advanced non-small cell lung cancer.
    Fidler MJ; Kim AW; Zusag T; Bonomi P
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiotherapy for lung cancer. Integration with chemotherapy].
    Moreno-Jiménez M; Aristu J
    Rev Med Univ Navarra; 2007; 51(4):13-33. PubMed ID: 18303657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy.
    Chang JY; Komaki R; Sasaki R; Liao Z; Stevens CW; Lu C; Fossella FV; Allen PK; Cox JD; Spitz MR; Wu X
    Clin Cancer Res; 2005 Apr; 11(8):2894-8. PubMed ID: 15837739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoradiation therapy optimization for stage III NSCLC].
    Mornex F
    Rev Pneumol Clin; 2003 Nov; 59(5 Pt 2):S15-20. PubMed ID: 14707908
    [No Abstract]   [Full Text] [Related]  

  • 10. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multimodal therapy of small cell and non-small cell lung carcinoma].
    Serke M; Kollmeier J
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1221-4. PubMed ID: 17520508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two patients with advanced non-small cell lung cancer (stage IIIB) who still responded very well to combined chemotherapy and radiotherapy].
    Koning CC; van Zandwijk N
    Ned Tijdschr Geneeskd; 2005 Jun; 149(23):1289-93. PubMed ID: 15960136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stage IIIB non-small cell lung cancer. Optimization of radiotherapy in lung cancer: some interesting questions to be solved].
    Girard N; Mornex F
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S61-16S67. PubMed ID: 17268338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative radiotherapy in non-small-cell lung cancer warrants further exploration in the era of adjuvant chemotherapy and conformal radiotherapy.
    Bonner JA; Spencer SA
    J Clin Oncol; 2006 Jul; 24(19):2978-80. PubMed ID: 16769984
    [No Abstract]   [Full Text] [Related]  

  • 15. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
    Johnson DH; Rusch VW; Turrisi AT
    J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
    [No Abstract]   [Full Text] [Related]  

  • 16. [Specificities of resectable Stage III non-small-cell lung cancer].
    Thibout Y; Cortot A; Mornex F
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S5-4S7. PubMed ID: 15687985
    [No Abstract]   [Full Text] [Related]  

  • 17. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
    Jaklitsch MT; Herndon JE; DeCamp MM; Richards WG; Kumar P; Krasna MJ; Green MR; Sugarbaker DJ
    J Surg Oncol; 2006 Dec; 94(7):599-606. PubMed ID: 17039491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
    Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA; Brown RC
    Radiology; 2000 Jun; 215 Suppl():1363-72. PubMed ID: 11037552
    [No Abstract]   [Full Text] [Related]  

  • 19. Localized small-cell lung cancer: which type of thoracic radiotherapy and which time schedule.
    Stuschke M; Pöttgen C
    Lung Cancer; 2004 Aug; 45 Suppl 2():S133-7. PubMed ID: 15552793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy.
    Chen Y; Guo W; Lu Y; Zou B
    Radiother Oncol; 2008 Sep; 88(3):351-8. PubMed ID: 18722684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.